|
Accueil > Actualité
Pfizer: US, EU accept applications for lung cancer treatment
(CercleFinance.com) - The US and European health regulators have accepted to review Pfizer's dacomitinib for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC), the drugmaker said on Wednesday.
In the US, the Food and Drug Administration has even granted a priority review for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR-activating mutations, it added. The European Medicines Agency has also accepted the marketing authorization application for dacomitinib for the same indication, Pfizer added. Copyright (c) 2018 CercleFinance.com. All rights reserved. |
19/04/2024 18:06
Alstoma conclu un accord avec Knorr-Bremse 19/04/2024 17:30 Danoneen hausse après deux analyses positives 19/04/2024 16:35 TotalEnergiespartenariat avec OK Petroleum aux USA 19/04/2024 16:29 BAE Systemsmodernise une usine de munitions 19/04/2024 16:15 Netflixle titre trébuche après une publication contrastée 19/04/2024 16:09 Bayersigne un contrat de fourniture d'énergie renouvelables Tous les articles sociétés |
